NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
17.52
-0.30 (-1.68%)
Apr 1, 2025, 4:00 PM EDT - Market closed
NovoCure Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 163.77 | 240.82 | 115.33 | 208.8 | 234.67 | Upgrade
|
| Short-Term Investments | 796.11 | 669.8 | 854.1 | 728.9 | 607.9 | Upgrade
|
| Cash & Short-Term Investments | 959.87 | 910.62 | 969.43 | 937.7 | 842.58 | Upgrade
|
| Cash Growth | 5.41% | -6.07% | 3.38% | 11.29% | 158.39% | Upgrade
|
| Accounts Receivable | 74.23 | 61.22 | 86.26 | 93.57 | 96.7 | Upgrade
|
| Other Receivables | 3.33 | 5.26 | 12.39 | 8.42 | 13.36 | Upgrade
|
| Receivables | 77.55 | 66.48 | 98.65 | 101.99 | 110.06 | Upgrade
|
| Inventory | 35.09 | 38.15 | 29.38 | 24.43 | 27.42 | Upgrade
|
| Prepaid Expenses | 7.32 | 6.85 | 6.42 | 4.76 | 4.12 | Upgrade
|
| Restricted Cash | 2.33 | 1.74 | 0.51 | 0.81 | 11.5 | Upgrade
|
| Other Current Assets | 24.41 | 10.56 | 7.15 | 3.84 | 3.77 | Upgrade
|
| Total Current Assets | 1,107 | 1,034 | 1,112 | 1,074 | 999.44 | Upgrade
|
| Property, Plant & Equipment | 119.59 | 97.7 | 68.96 | 53.88 | 41.63 | Upgrade
|
| Other Long-Term Assets | 14.62 | 14.02 | 11.16 | 12.09 | 10.91 | Upgrade
|
| Total Assets | 1,241 | 1,146 | 1,192 | 1,139 | 1,052 | Upgrade
|
| Accounts Payable | 105.09 | 94.39 | 85.2 | 72.6 | 53.65 | Upgrade
|
| Accrued Expenses | 70.98 | 60.18 | 49.44 | 45.39 | 35.66 | Upgrade
|
| Current Portion of Long-Term Debt | 558.16 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 7.91 | - | - | - | - | Upgrade
|
| Current Unearned Revenue | 14.23 | 16.22 | 18.03 | 17.76 | 17.77 | Upgrade
|
| Other Current Liabilities | 0.01 | 8.32 | 6.11 | 6.85 | 6.54 | Upgrade
|
| Total Current Liabilities | 756.38 | 179.12 | 158.78 | 142.6 | 113.61 | Upgrade
|
| Long-Term Debt | 97.3 | 568.82 | 565.58 | 562.23 | 429.95 | Upgrade
|
| Long-Term Leases | 19.97 | 27.42 | 18.76 | 13 | 14.29 | Upgrade
|
| Long-Term Unearned Revenue | - | - | 2.88 | 6.48 | 12.14 | Upgrade
|
| Other Long-Term Liabilities | 0.02 | 0.02 | 0.08 | 0.15 | 0.3 | Upgrade
|
| Total Liabilities | 880.61 | 783.63 | 750.48 | 729 | 575.46 | Upgrade
|
| Additional Paid-In Capital | 1,520 | 1,353 | 1,222 | 1,100 | 1,111 | Upgrade
|
| Retained Earnings | -1,154 | -985.5 | -778.46 | -685.93 | -631.08 | Upgrade
|
| Comprehensive Income & Other | -5.5 | -5.47 | -2.43 | -3.17 | -3.83 | Upgrade
|
| Shareholders' Equity | 360.18 | 362.5 | 441.17 | 410.49 | 476.53 | Upgrade
|
| Total Liabilities & Equity | 1,241 | 1,146 | 1,192 | 1,139 | 1,052 | Upgrade
|
| Total Debt | 683.34 | 596.24 | 584.34 | 575.23 | 444.24 | Upgrade
|
| Net Cash (Debt) | 276.53 | 314.37 | 385.08 | 362.48 | 398.34 | Upgrade
|
| Net Cash Growth | -12.04% | -18.36% | 6.24% | -9.00% | 145.19% | Upgrade
|
| Net Cash Per Share | 2.56 | 2.95 | 3.68 | 3.50 | 3.66 | Upgrade
|
| Filing Date Shares Outstanding | 109.92 | 107.09 | 105.46 | 104.42 | 102.41 | Upgrade
|
| Total Common Shares Outstanding | 108.52 | 107.08 | 105.05 | 103.97 | 102.33 | Upgrade
|
| Working Capital | 350.2 | 855.29 | 952.75 | 930.92 | 885.83 | Upgrade
|
| Book Value Per Share | 3.32 | 3.39 | 4.20 | 3.95 | 4.66 | Upgrade
|
| Tangible Book Value | 360.18 | 362.5 | 441.17 | 410.49 | 476.53 | Upgrade
|
| Tangible Book Value Per Share | 3.32 | 3.39 | 4.20 | 3.95 | 4.66 | Upgrade
|
| Land | 34.53 | 24.7 | 15.99 | 11.16 | - | Upgrade
|
| Machinery | 63.31 | 43.05 | 30.94 | 26.56 | 23.32 | Upgrade
|
| Leasehold Improvements | 12.13 | 11.7 | 9.35 | 7.08 | 6.5 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.